Preprandial Ghrelin Effect

PHASE1CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

January 11, 2017

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2018

Conditions
Type 2 Diabetes
Interventions
DRUG

Ghrelin

Boluses of Ghrelin will be given over a 1 minute period at 3 ug/kg. Ensure (2 cans) will also be given.

OTHER

Saline

Boluses of saline will be given over a 1 minute period. Ensure (2 cans) will also be given.

Trial Locations (1)

27705

Duke Center For Living, Durham

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Jenny Tong, MD, MPH

OTHER

NCT02913703 - Preprandial Ghrelin Effect | Biotech Hunter | Biotech Hunter